Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier.

André S, Ansciaux E, Saidi E, Larbanoix L, Stanicki D, Nonclercq D, Elst LVander, Laurent S, Muller RN, Burtea C
J Alzheimers Dis. 2017; 60(4):1547-1565. PMID: 29036827. Abstract